Page 2 - Inscripta Inc News Today

Willow Biosciences Announces Participation In Synbiobeta Panel Discussion News provided by Share this article Willow" or the " Company") (TSX: WLLW) (OTCQX: CANSF), a Canadian biotechnology company that manufactures ultra-pure, sustainably produced cannabinoids via yeast-based biosynthesis, is pleased to announce that it will be presenting on a panel with other industry leaders at SynBioBetas "Celebrating Synthetic Biology Breakthroughs in Biopharma" conference on May 26, 2021. Panel details T...

The ongoing pandemic has created a wealth of interest from venture capital investors and the broader public in what biotech companies are able to achieve if it’s flush with resources. That was the sentiment of a group of Boulder area biotechnology industry leaders, who met virtually at BizWest’s CEO Roundtable on the biotechnology industry Tuesday morning. Steady stream of investor dollars Biotech was one of the few industries that was relatively unaffected from a financial standpoint durin...

DENVER — The Colorado Bioscience Association said the state’s biotech industry set a record for new venture funding in the first quarter of 2021, with a lion’s share of those dollars coming from Boulder-area companies. The trade association said Tuesday that biotech companies in the state raised $704 million in the last quarter. That figure is more than half of the $1.2 billion in venture funding issued in the entirety of 2020 and well on its way toward eclipsing the $850 million or so is...

ADVERTISEMENT ADVERTISEMENT Colorado-Based Biotech Co. Grabs $175M In Series E Law360 (April 5, 2021, 8:32 PM EDT) -- Inscripta Inc., a Colorado-based gene editing technology company, secured $150 million in a financing round led by Fidelity Management & Research Company LLC with advice from T. Rowe Price Associates Inc., according to an announcement Monday. The Series E round featured new investors D1 Capital Partners and Durable Capital Partners LP and returning investors including Foresite ...

ADVERTISEMENT ADVERTISEMENT Colorado-Based Biotech Co. Grabs $150M In Series E Law360 (April 5, 2021, 8:32 PM EDT) -- Inscripta Inc., a Colorado-based gene editing technology company, secured $150 million in a financing round led by Fidelity Management & Research Company LLC with advice from T. Rowe Price Associates Inc., according to an announcement Monday. The Series E round featured new investors D1 Capital Partners and Durable Capital Partners LP and returning investors including Foresite ...

BOULDER — Genomic-editing platform developer Inscripta Inc. said it raised $150 million in its Series E funding round, marking yet another multi-million funding haul for biotech companies in the Boulder area. In a statement, the company said the round was co-led by Fidelity Management & Research Co. LLC and T. Rowe Price Group Inc. (Nasdaq: TROW). It brings Inscripta’s total investments from venture capital to more than $410 million since it was founded in 2015, and eclipses its $125 millio...

Search jobs 01-Apr-2021 Global CRISPR and CRISPR-associated (Cas) Genes Market to 2026 with Profiles of OriGene Technologies, Thermo Fisher Scientific, Takara Bio, Horizon Discovery, Addgene and More - ResearchAndMarkets.com ResearchAndMarkets.coms offering. The CRISPR and CRISPR-associated (Cas) Genes Market was estimated to be USD 1,563.52 million in 2020 and is poised to grow at a CAGR of 15.67% to reach USD 3,733.66 million by the year 2026. The ...